Study title: Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.La Grutta S , Nicolini G, Capristo C, Bellodi SC, Rossi GA (Monaldi Arch Chest Dis. 2007 Mar;67:30-8.)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: please see report | |||||
MAH holders: please see report | |||||
Assessment: | |||||
Active substance: BECLAMETHASONE | |||||
ATC code: | |||||
Document link: MC.PR.1400.003.01 publication.pdf | |||||
Document date: 2015-03-02 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |